MENU
+Compare
CUE
Stock ticker: NASDAQ
AS OF
Jun 26, 04:57 PM (EDT)
Price
$0.78
Change
+$0.06 (+8.33%)
Capitalization
59.48M

CUE Cue Biopharma Forecast, Technical & Fundamental Analysis

Cue Biopharma Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
CUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CUE with price predictions
Jun 25, 2025

CUE's RSI Oscillator ascends from oversold territory

The RSI Oscillator for CUE moved out of oversold territory on June 18, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 41 similar instances when the indicator left oversold territory. In of the 41 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 18, 2025. You may want to consider a long position or call options on CUE as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CUE just turned positive on June 03, 2025. Looking at past instances where CUE's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

CUE moved above its 50-day moving average on June 24, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where CUE advanced for three days, in of 210 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CUE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CUE broke above its upper Bollinger Band on June 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CUE entered a downward trend on June 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.042) is normal, around the industry mean (16.539). P/E Ratio (0.000) is within average values for comparable stocks, (59.016). CUE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.300). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (6.177) is also within normal values, averaging (255.605).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CUE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CUE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CUE is expected to report earnings to fall 17.65% to -14 cents per share on September 08

Cue Biopharma CUE Stock Earnings Reports
Q2'25
Est.
$-0.14
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.04
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.08
The last earnings report on May 13 showed earnings per share of -17 cents, missing the estimate of -15 cents. With 102.81K shares outstanding, the current market capitalization sits at 59.48M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
40 Guest Street
Phone
+1 617 949-2680
Employees
53
Web
https://www.cuebiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GMM2.550.06
+2.29%
Global Mofy AI Limited
AUDC9.740.16
+1.67%
AudioCodes Ltd
LZB37.540.46
+1.24%
La-Z-Boy
KT20.120.20
+1.00%
KT Corp.
ARM158.150.84
+0.53%
Arm Holdings plc

CUE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CUE has been loosely correlated with DNLI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CUE jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CUE
1D Price
Change %
CUE100%
+8.67%
DNLI - CUE
39%
Loosely correlated
+0.35%
VCYT - CUE
36%
Loosely correlated
-1.60%
SGMT - CUE
35%
Loosely correlated
-8.34%
AXON - CUE
33%
Loosely correlated
-1.16%
INAB - CUE
33%
Poorly correlated
-2.68%
More